StockTipsArenaBeta

BUY Blue Star — IDBI Capital

BUYBlue Star
Blue Star share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))11 Sept 2026via IDBI Capital Research Calls Telegram

Entry₹1,560Stated
Target₹1,630
Total upside +4.49% (call closed)
Stop loss₹1,520-2.56% risk
Exit₹1,52015 Sept 2026, 11:00 am
Stop-loss hit-2.56%
Follow IDBI Capital for new calls(26% target hit, 389 closed calls)Get alertsWatch BLUESTARCO for new buy/sell callsGet alertsSee 209 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 15 Sept 2026
2 supporting3 neutral3 opposing
Supports the BUY call (2)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·11 Sept · 4d ago

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·11 Sept · 4d ago

Neutral / worth noting (3)

Somerset-backed Cyrix Healthcare acquires Blue Star’s medtech business

NewsGoogle News·7 Sept · 1w ago

(opens in new tab)

Cyrix Healthcare acquires Blue Star E&E's MedTech Solutions business

NewsGoogle News·5 Sept · 1w ago

(opens in new tab)

Cyrix Healthcare acquires Blue Star E&E’s MedTech business

NewsGoogle News·4 Sept · 1w ago

(opens in new tab)
Weighs against the BUY call (3)

Blue Star sees no Q2 margin recovery as raw material costs bite

NewsGoogle News·8 Sept · 6d ago

(opens in new tab)

Blue Star Share Price Falls 2.33%: Technicals, Valuation

NewsGoogle News·8 Sept · 1w ago

(opens in new tab)

Blue Star Reports Ongoing Q2 Challenges Amid Input Price Inflation

NewsGoogle News·8 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Blue Star

All analyst calls on Blue Star

More from IDBI Capital

Every call and its outcome